Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity : an Open-label, Non-inferiority, Multicenter, Randomized Phase III Trial

NCT07072000 is registered in ClinicalTrials.gov with Hai-Qiang Mai,MD,PhD as lead sponsor.

NCT NCT07072000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07072000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity : an Open-label, Non-inferiority, Multicenter, Randomized Phase III Trial
Lead sponsor
Hai-Qiang Mai,MD,PhD
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
July 31, 2032
Enrollment
550 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal cancinoma (npc)